Skip to main content
. 2020 Dec 22;14(2):100987. doi: 10.1016/j.tranon.2020.100987

Fig. 7.

Fig. 7

MiR-506-3p, EZH2 and β-catenin expression in an orthotopic mouse model of ovarian cancer.

(A) MiR-506–3p expression in HeyA8-ip1 tumors from control and miR-506-3p treated mice was assessed by miRNA in situ hybridization. (B-D) Samples of HeyA8-ip1 tumors from control and miR-506-3p treated mice were subjected to IHC staining for EZH2 and β-catenin; Expression of EZH2 and β-catenin protein was calculated as IHC staining scores.